Who owns BIOGEN INC.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of BIIB from SEC Form 13F filings across 1,057 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 1,057 institutions disclosed 140.1M shares of BIOGEN INC. worth $31.65B — about 94.8% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
1,057
13F holders
$31.65B
value, 2026 filers
94.8%
of shares outstanding (140.1M sh)
117
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of BIIB's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 16.8M | $3.79B | 0.2% | 11.4% | -7.9% |
| 2 | BlackRock, Inc. | 16.1M | $3.63B | 0.1% | 10.9% | +0.6% |
| 3 | PRIMECAP MANAGEMENT CO/CA/ | 15.2M | $3.43B | 2.1% | 10.3% | +0.3% |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 9.7M | $2.18B | 0.0% | 6.5% | +0.2% |
| 5 | STATE STREET CORP | 7.6M | $1.71B | 0.0% | 5.1% | +3.0% |
| 6 | VANGUARD PORTFOLIO MANAGEMENT LLC | 6.6M | $1.48B | 0.1% | 4.4% | -0.5% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 4.5M | $1.01B | 0.1% | 3% | +1.3% |
| 8 | WELLINGTON MANAGEMENT GROUP LLP | 3.5M | $781.3M | 0.1% | 2.3% | +10.9% |
| 9 | MORGAN STANLEY | 2.5M | $566.1M | 0.0% | 1.7% | +3.9% |
| 10 | JPMORGAN CHASE & CO | 2.0M | $463.0M | 0.0% | 1.4% | +11.8% |
| 11 | Invesco Ltd. | 2.0M | $445.6M | 0.0% | 1.3% | +9.3% |
| 12 | CITADEL ADVISORS LLC | 1.6M | $359.6M | 0.0% | 1.1% | +280.6% |
| 13 | Legal & General Group Plc | 1.5M | $342.2M | 0.1% | 1% | +1.4% |
| 14 | AQR CAPITAL MANAGEMENT LLC | 1.5M | $341.3M | 0.1% | 1% | -22.0% |
| 15 | NORTHERN TRUST CORP | 1.4M | $324.2M | 0.0% | 1% | +0.4% |
| 16 | Amundi | 1.3M | $297.4M | 0.1% | 0.9% | -13.2% |
| 17 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1.2M | $270.1M | 0.0% | 0.8% | -4.7% |
| 18 | BANK OF AMERICA CORP /DE/ | 1.2M | $265.2M | 0.0% | 0.8% | +5.2% |
| 19 | DIMENSIONAL FUND ADVISORS LP | 1.2M | $261.6M | 0.0% | 0.8% | +0.8% |
| 20 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.1M | $248.7M | 0.0% | 0.7% | -1.5% |
| 21 | FRED ALGER MANAGEMENT, LLC | 1.0M | $233.9M | 0.7% | 0.7% | +31.4% |
| 22 | UBS Group AG | 997,155 | $225.2M | 0.0% | 0.7% | -3.2% |
| 23 | GOLDMAN SACHS GROUP INC | 932,995 | $210.7M | 0.0% | 0.6% | -24.2% |
| 24 | Boston Partners | 901,213 | $203.6M | 0.2% | 0.6% | -28.7% |
| 25 | PRICE T ROWE ASSOCIATES INC /MD/ | 873,151 | $197.2M | 0.0% | 0.6% | +12.8% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.